Symbol |
Name |
1060P11.3
|
killer cell immunoglobulin-like receptor, three domains, pseudogene
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
ACTG2
|
actin, gamma 2, smooth muscle, enteric
|
ADARB1
|
adenosine deaminase, RNA-specific, B1
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase)
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
AMACR
|
alpha-methylacyl-CoA racemase
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
CA12
|
carbonic anhydrase XII
|
CCP110
|
centriolar coiled coil protein 110kDa
|
CDC45
|
cell division cycle 45
|
CPA3
|
carboxypeptidase A3 (mast cell)
|
CRYAB
|
crystallin, alpha B
|
CTSH
|
cathepsin H
|
CYB5A
|
cytochrome b5 type A (microsomal)
|
CYP4B1
|
cytochrome P450, family 4, subfamily B, polypeptide 1
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
FBLN1
|
fibulin 1
|
FBN2
|
fibrillin 2
|
FGF9
|
fibroblast growth factor 9
|
GATA2
|
GATA binding protein 2
|
GATA3
|
GATA binding protein 3
|
GLUL
|
glutamate-ammonia ligase
|
GPER1
|
G protein-coupled estrogen receptor 1
|
GSTA4
|
glutathione S-transferase alpha 4
|
GSTT1
|
glutathione S-transferase theta 1
|
GULP1
|
GULP, engulfment adaptor PTB domain containing 1
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
HMOX1
|
heme oxygenase 1
|
HOPX
|
HOP homeobox
|
HSPB8
|
heat shock 22kDa protein 8
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
IFI27
|
interferon, alpha-inducible protein 27
|
IFI44L
|
interferon-induced protein 44-like
|
IFI6
|
interferon, alpha-inducible protein 6
|
IFIT1
|
interferon-induced protein with tetratricopeptide repeats 1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2
|
ITM2A
|
integral membrane protein 2A
|
KIAA0355
|
KIAA0355
|
KRT6A
|
keratin 6A, type II
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
LRRN3
|
leucine rich repeat neuronal 3
|
MAGEA3
|
melanoma antigen family A3
|
MAGEA6
|
melanoma antigen family A6
|
MAGED1
|
melanoma antigen family D1
|
ME1
|
malic enzyme 1, NADP(+)-dependent, cytosolic
|
MYLK
|
myosin light chain kinase
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2
|
NOTCH3
|
notch 3
|
NUPR1
|
nuclear protein, transcriptional regulator, 1
|
PDLIM1
|
PDZ and LIM domain 1
|
PDZK1
|
PDZ domain containing 1
|
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
PLS3
|
plastin 3
|
PODXL
|
podocalyxin-like
|
PPAP2A
|
phosphatidic acid phosphatase type 2A
|
PPIC
|
peptidylprolyl isomerase C (cyclophilin C)
|
PRAME
|
preferentially expressed antigen in melanoma
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
RGCC
|
regulator of cell cycle
|
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic)
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1
|
S100A14
|
S100 calcium binding protein A14
|
S100A8
|
S100 calcium binding protein A8
|
S100A9
|
S100 calcium binding protein A9
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
TPSAB1
|
tryptase alpha/beta 1
|
TPSB2
|
tryptase beta 2 (gene/pseudogene)
|
VEGFA
|
vascular endothelial growth factor A
|